Clin2
NCT07231744Likely a fitNot yet recruiting

Safety study of STLX-2012 in healthy volunteers

Healthy Participants

This trial tests the safety of a new drug called STLX-2012 in healthy people. It helps researchers understand how the drug works in the body before testing it in patients with a disease.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
32 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • You are between 18 and 55 years old.
  • You have a body mass index (BMI) between 18 and 32.
  • You are in good general health.
  • Your liver and kidneys are working well.
  • You are willing to use birth control for 30 days after the last dose if you or your partner can become pregnant.
  • You have not had a bad allergic reaction to any medicine or taken a drug similar to STLX-2012 before.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07140055Not yet recruiting· Phase 1
Study of BLX-7006 in healthy adults

This trial tests a new medicine called BLX-7006 in healthy volunteers to see how safe it is and how the body handles it. It helps researchers decide if the drug can be tested in patients with a medical condition later.

Brisbane, Queensland
NCT07678463Recruiting· Phase 1
Testing a new medicine in healthy volunteers

This study tests a new experimental medication (QX-4533) in healthy volunteers to find the best dose and see how it works in the body. It involves taking the medication and having your health monitored closely over time.

Brisbane, Queensland
NCT07352423Recruiting· Phase 1
Safety study of ALXN2230 in healthy volunteers

This trial tests the safety and how the body handles a new drug called ALXN2230 in healthy people. It helps find the right dose and checks for side effects.

London
NCT07140081Not yet recruiting· Phase 1
Study of BLX-0871 in healthy volunteers

This trial tests a new medication called BLX-0871 in healthy adults to see how safe it is and how the body processes it. If you are generally healthy and meet the age, weight, and lifestyle requirements, you may be able to join.

Melbourne, New South Wales
NCT07580794Recruiting· Phase 1
Safety Study of New Drug HSK56630 in Healthy People

This is an early-stage safety test of a new investigational drug called HSK56630 in healthy volunteers with no major medical conditions. Researchers will monitor how your body tolerates the drug and what side effects might occur.

Bayswater, Victoria
NCT07522970Recruiting· Phase 1
Safety and Tolerability Study of LG-0317 in Healthy Adults

This early-stage study tests a new experimental drug called LG-0317 in healthy volunteers to see if it is safe and how the body processes it. If you are healthy and meet the basic requirements, this trial may help advance a new treatment option.

Shanghai, Shanghai Municipality

Hear when a new Healthy Participants trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.